AI blood test finds silent liver disease years before symptoms

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

AI Summary: Researchers unveiled an AI‑driven liquid biopsy that scans genome‑wide cell‑free DNA fragment patterns to flag liver fibrosis, cirrhosis and chronic liver disease well before symptoms appear. Early results indicate the test can identify disease signals years ahead of clinical diagnosis, offering a shot at much earlier intervention — if practice and payers cooperate.

#healthcare #publichealth #biotech #digitalhealth #medicaldevices #healthcarefinance

5 months / oncodaily

5 months / medicalxpress

5 months / oncodaily

5 months / oncodaily

5 months / sciencedaily

5 months / medicalxpress


Back to Top / Fri, March 6, 2026, 1:22 am / permalink 20251 / 7 stories in 5 months /




Related Stories


JAMA tightens rules on AI use in medical publishing / 15 days

Abridge and NVIDIA partner to build healthcare AI model / 2 months

Smartphone app improves premature ejaculation outcomes in randomized trial / 5 months

DeepRare AI beats clinicians at diagnosing rare diseases / 6 months

Grail’s Galleri blood test misses UK study goal; investor jitters / 6 months

FDA clears wearable electric-field therapy for pancreatic cancer patients / 6 months

Senate Republicans block repeal of Medicare AI prior authorization pilot / 6 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Clinical Trials, Wildlife, Research Funding, Neuroscience and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.